SEC Form 4 · accession 0001645627-18-000039
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Jul 19, 2018
Accepted (ET)
Jul 26, 2018 · 8:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 19, 2018 | P | 1,000 | $0.0355 | A | 25,201,298 | D | |
| Common Stock | Jul 19, 2018 | P | 2,000 | $0.034 | A | 25,203,298 | D | |
| Common Stock | Jul 19, 2018 | P | 1,000 | $0.0336 | A | 25,204,298 | D | |
| Common Stock | Jul 19, 2018 | P | 1,000 | $0.0336 | A | 25,205,298 | D | |
| Common Stock | Jul 19, 2018 | P | 1,000 | $0.036 | A | 25,206,298 | D | |
| Common Stock | Jul 19, 2018 | P | 100 | $0.0355 | A | 25,206,398 | D | |
| Common Stock | Jul 20, 2018 | P | 1,000 | $0.0346 | A | 25,207,398 | D | |
| Common Stock | Jul 20, 2018 | P | 100 | $0.0339 | A | 25,207,498 | D | |
| Common Stock | Jul 20, 2018 | P | 1,000 | $0.0343 | A | 25,208,498 | D |
Table II — derivative securities
No Table II lines on this filing.